Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27381639)

Published in Sci Rep on July 06, 2016

Authors

Shun-Jun Fu1,2,3, Qiang Zhao1,2,3, Fei Ji1,2,3, Mao-Gen Chen1,2,3, Lin-Wei Wu1,2,3, Qing-Qi Ren1,2,3, Zhi-Yong Guo1,2,3, Xiao-Shun He1,2,3

Author Affiliations

1: Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
2: Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
3: Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.

Articles citing this

MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma. Oncotarget (2017) 0.75

Articles cited by this

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46

Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

Gamma glutamyl transferase. Crit Rev Clin Lab Sci (2001) 3.34

The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A (1970) 3.13

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation (2008) 2.48

Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol (2011) 1.63

gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab (2004) 1.52

Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res (2010) 1.40

Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol (2005) 1.39

Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis (1999) 1.30

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer (2011) 1.29

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut (2015) 1.16

Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB J (1999) 1.12

Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy. Med Oncol (2013) 1.12

Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer (2006) 1.03

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial. Br J Cancer (2012) 1.01

Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer (2013) 0.96

Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection. Surgery (2013) 0.93

γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study. Int J Cancer (2015) 0.91

Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma. Br J Cancer (2014) 0.90

γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma. Ann Surg Oncol (2014) 0.88

Alcoholic liver disease associated with increased gamma-glutamyltransferase activities in serum and liver. Adv Exp Med Biol (1980) 0.88

Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma. Dis Esophagus (2014) 0.86

Serum gamma-glutamyl-transferase independently predicts outcome after transarterial chemoembolization of hepatocellular carcinoma: external validation. Cardiovasc Intervent Radiol (2011) 0.83

Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg (2016) 0.83

Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev (2013) 0.83

Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -independent iron uptake by cancer cells. Cancer Cell Int (2003) 0.82

Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma. J Clin Pathol (2015) 0.79

Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy. Tumour Biol (2015) 0.79

Liver transplantation using organs from deceased organ donors: a single organ transplant center experience. Hepatobiliary Pancreat Dis Int (2014) 0.79

Disseminated tumor cells homing into rats' liver: a new possible mechanism of HCC recurrence. World J Gastroenterol (2004) 0.79

Association between gamma-glutamyltransferase levels and insulin resistance according to alcohol consumption and number of cigarettes smoked. J Atheroscler Thromb (2010) 0.77